IBDEI0NZ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11429,0)
 ;;=300.7^^50^647^2
 ;;^UTILITY(U,$J,358.3,11429,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11429,1,2,0)
 ;;=2^300.7
 ;;^UTILITY(U,$J,358.3,11429,1,5,0)
 ;;=5^Hyponchondriasis
 ;;^UTILITY(U,$J,358.3,11429,2)
 ;;=^60556
 ;;^UTILITY(U,$J,358.3,11430,0)
 ;;=300.81^^50^647^3
 ;;^UTILITY(U,$J,358.3,11430,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11430,1,2,0)
 ;;=2^300.81
 ;;^UTILITY(U,$J,358.3,11430,1,5,0)
 ;;=5^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,11430,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,11431,0)
 ;;=307.1^^50^648^1
 ;;^UTILITY(U,$J,358.3,11431,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11431,1,2,0)
 ;;=2^307.1
 ;;^UTILITY(U,$J,358.3,11431,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,11431,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,11432,0)
 ;;=307.51^^50^648^2
 ;;^UTILITY(U,$J,358.3,11432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11432,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,11432,1,5,0)
 ;;=5^Bulemia Nervosa
 ;;^UTILITY(U,$J,358.3,11432,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,11433,0)
 ;;=307.50^^50^648^3
 ;;^UTILITY(U,$J,358.3,11433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11433,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,11433,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,11433,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,11434,0)
 ;;=333.99^^50^649^2
 ;;^UTILITY(U,$J,358.3,11434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11434,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,11434,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,11434,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,11435,0)
 ;;=332.0^^50^649^3
 ;;^UTILITY(U,$J,358.3,11435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11435,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,11435,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,11435,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,11436,0)
 ;;=333.79^^50^649^1
 ;;^UTILITY(U,$J,358.3,11436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11436,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,11436,1,5,0)
 ;;=5^Acquired Torsion Dystonia NEC
 ;;^UTILITY(U,$J,358.3,11436,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,11437,0)
 ;;=333.85^^50^649^4
 ;;^UTILITY(U,$J,358.3,11437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11437,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,11437,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,11437,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,11438,0)
 ;;=V87.39^^50^650^1
 ;;^UTILITY(U,$J,358.3,11438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11438,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,11438,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,11438,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,11439,0)
 ;;=310.0^^50^651^1
 ;;^UTILITY(U,$J,358.3,11439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11439,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,11439,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,11439,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,11440,0)
 ;;=310.1^^50^651^3
 ;;^UTILITY(U,$J,358.3,11440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11440,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,11440,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,11440,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,11441,0)
 ;;=310.2^^50^651^4
 ;;^UTILITY(U,$J,358.3,11441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11441,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,11441,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,11441,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,11442,0)
 ;;=310.81^^50^651^5
 ;;^UTILITY(U,$J,358.3,11442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11442,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,11442,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;
 ;;$END ROU IBDEI0NZ
